'The Next Big Idea: Creating a New Venture'
The media are cordially invited to attend a special Yale-CURE BioHaven
event that will take a look into the future at the next generation of medical
therapeutics.
The panel discussion -- "The Next Big Idea: Creating a New Venture" --
will be held on Wednesday, April 16 in the Anlyan Center Auditorium at 300
Cedar Street, New Haven, beginning at 5 p.m. The program will feature
presentations by leading industry observers on new trends in bioscience
business formation.
A capacity audience is expected, but tickets have been reserved for
members of the press with valid credentials. Please contact lmalis@curenet.org
to reserve your place.
Roger Longman, managing partner of Windhover Information Inc. and a
leading expert in biopharmaceutical deal making, will serve as moderator.
The panelists are:
* William Burkoth, the senior manager of venture capital of Pfizer Venture
Investments, Pfizer Inc., a board observer for five Pfizer-supported new
ventures.
* Richard Flavell, professor and chair of immunobiology; professor of
molecular, cellular & developmental biology at Yale University; Howard
Hughes Medical Institute Investigator; and a founding scientist of
Vaxinnate.
* Haifan Lin, professor of cell biology, director of the Yale Stem Cell
Center in Yale School of Medicine, and internationally recognized stem
cell researcher.
* David Sheer, president of Sheer & Company, Inc., venture capitalist and
expert in life sciences company formation.
Further details and directions to the event are available online at
http://curenet.org/bigidea .
The BioHaven Entrepreneurship Series is sponsored by the Yale Office of
Cooperative Research, Connecticut United for Research Excellence (CURE),
Wiggin and Dana, LLP, Elm Street Ventures, and Price Waterhouse Coopers, PC,
with support from the Yale Entrepreneurial Society and the Yale Biotechnology
& Pharmaceutical Society.
Contact: Bill Kelly, +1-203-375-2696, bill@harveymalis.com
SOURCE CURE
